RZLT
NASDAQStockRezolute, Inc.
$3.06-0.13 (-3.93%)
52-Week Range
$1.40
$10.94
Key Stats
Market Cap
292.4M
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.64
Volume
888.8K
Avg Volume
1.6M
Performance
1M
-10.39%
3M
+85.28%
6M
-59.57%
YTD
+39.49%
1Y
-19.25%
3Y
+33.04%
5Y
-65.49%
Price Chart
ETF Exposure
RZLT is held by 48 ETFs
| ETF | Fund Name | Weight |
|---|---|---|
| BBC | Virtus Biotech Clinical Trials ETF | 1.32% |
| SBIO | ALPS Medical Breakthroughs ETF | 0.19% |
| XBI | State Street SPDR S&P Biotech ETF | 0.09% |
| IWC | iShares Micro-Cap ETF | 0.05% |
| GSSC | Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | 0.04% |
| LABU | Direxion Daily S&P Biotech Bull 3X ETF | 0.02% |
| PWS | Pacer WealthShield ETF | 0.02% |
| VTWG | Vanguard Russell 2000 Growth ETF | 0.01% |
| DFAS | Dimensional - US Small Cap ETF | 0.01% |
| ISCG | iShares Morningstar Small-Cap Growth ETF | 0.01% |
| IWM | iShares Russell 2000 ETF | 0.01% |
| JKK | iShares Morningstar Small-Cap Growth ETF | 0.01% |
| VTWO | Vanguard Russell 2000 ETF | 0.01% |
| RESM | Columbia Research Enhanced Small Cap ETF | 0.01% |
| RSSL | Global X - Russell 2000 ETF | 0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | 0.01% |
| UWM | ProShares - Ultra Russell2000 | 0.01% |
| URTY | ProShares - UltraPro Russell2000 | 0.01% |
| ISCB | iShares Morningstar Small-Cap ETF | 0.00% |
| JKJ | iShares Morningstar Small-Cap ETF | 0.00% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 0.00% |
| VHT | Vanguard Health Care ETF | 0.00% |
| VXF | Vanguard Extended Market ETF | 0.00% |
| IWN | iShares Russell 2000 Value ETF | 0.00% |
| SMMD | iShares Russell 2500 ETF | 0.00% |
| VTWV | Vanguard Russell 2000 Value ETF | 0.00% |
| HDG | ProShares - Hedge Replication ETF | 0.00% |
| DFAC | Dimensional - US Core Equity 2 ETF | 0.00% |
| DFAU | Dimensional - US Core Equity Market ETF | 0.00% |
| DFUS | Dimensional - US Equity Market ETF | 0.00% |
| ITDB | iShares LifePath Target Date 2030 ETF | 0.00% |
| ITDC | iShares LifePath Target Date 2035 ETF | 0.00% |
| ITDD | iShares LifePath Target Date 2040 ETF | 0.00% |
| ITDE | iShares LifePath Target Date 2045 ETF | 0.00% |
| ITDF | iShares LifePath Target Date 2050 ETF | 0.00% |
| ITDG | iShares LifePath Target Date 2055 ETF | 0.00% |
| ITDH | iShares LifePath Target Date 2060 ETF | 0.00% |
| ITDI | iShares LifePath Target Date 2065 ETF | 0.00% |
| ITDJ | iShares LifePath Target Date 2070 ETF | 0.00% |
| ITOT | iShares Core S&P Total U.S. Stock Market ETF | 0.00% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| SCHB | Schwab U.S. Broad Market ETF | 0.00% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
| VTHR | Vanguard Russell 3000 ETF | 0.00% |
| VTI | Vanguard Total Stock Market ETF | 0.00% |
About RZLT ETF Exposure
Rezolute, Inc. (RZLT) is held by 48 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 292.4M, RZLT is a widely held institutional stock. The stock currently trades at $3.06. Investors can gain exposure to RZLT through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RZLT, sorted by portfolio weight.